SCHEMBL23491306

SCHEMBL23491306

CCc1ccc(O)c(C=N)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.63
ALOX12 P18054 5/20 0.49
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 4/20 0.49
ALOX15 P16050 4/20 0.49
USP2 O75604 3/20 0.49
MAPT P10636 3/20 0.49
GAA P10253 2/20 0.49
HTT P42858 2/20 0.49
XDH P47989 1/20 0.42
CDK1 P06493 1/20 0.42
POLB P06746 3/20 0.41
PSMD14 O00487 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
MEN1 O00255 2/20 0.38
ESR1 P03372 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14345794 0.86 TRPA1 (0.59) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL305074 0.80 CDK1 (0.65) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL28738145 0.78 TRPA1 (0.55) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL56556 0.78 TRPA1 (1.00) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL30290839 0.78 TRPA1 (1.00) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL18768241 0.78 TRPA1 (0.43) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL17548948 0.77 MAPT (0.54) TRPA1ALOX12KDM4EALDH1A1HSD17B10
SCHEMBL19315909 0.76 TRPA1 (0.42) TRPA1KDM4EALDH1A1MAPTGAA
SCHEMBL19497948 0.75 MCL1 (0.55) TRPA1KDM4EHSD17B10CYP3A4CNR1
SCHEMBL12693941 0.74 TRPA1 (0.41) TRPA1ALOX12KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 TRPA1 1736/4885ALOX12 2656/4885KDM4E 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.